Microvascular dysfunction in cardiac syndrome X: The role of inflammation

CMAJ. Canadian Medical Association Journal

Volumn 174, Issue 13, 2006, Pages 1833-1834

  Arroyo Espliguero, Ramón ^a   Kaski, Juan Carlos ^b  

^a HOSPITAL UNIVERSITARIO DE GUADALAJARA   (Spain)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENDOTHELIN 1; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ANGINA PECTORIS; CARDIAC SYNDROME X; CORONARY ARTERY BLOOD FLOW; DIFFERENTIAL DIAGNOSIS; ENDOTHELIAL DYSFUNCTION; HEALTH CARE SYSTEM; HEART DISEASE; HUMAN; INFLAMMATION; MICROANGIOPATHY; QUALITY OF LIFE; SHORT SURVEY; SYNDROME X;

EID: 33745668642     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.051331     Document Type: Short Survey

References (5)

1. Kaski JC, Rosano GM, Collins P, et al. Cardiac syndrome X: clinical characteristics and left ventricular function. Long-term follow-up study. J Am Coll Cardiol 1995;25:807-14.
2. Masci PG, Laclaustra M, Lara JG, et al. Brachial artery flow-mediated dilation and myocardial perfusion in patients with cardiac syndrome X. Am J Cardiol 2005;95:1478-80.
3. Arroyo-Espliguero R, Mollichelli N, Avanzas P, et al. Chronic inflammation and increased arterial stiffness in patients with cardiac syndrome X. Eur Heart J 2003;24:2006-11.
4. Cosin-Sales J, Pizzi C, Brown S, et al. C-reactive protein, clinical presentation, and ischemic activity in patients with chest pain and normal coronary angiograms. J Am Coll Cardiol 2003;41: 1468-74.
5. Kaski JC, Aldama G, Cosín-Sales J. Cardiac syndrome X. Diagnosis, pathogenesis and management. Am J Cardiovasc Drugs 2004;4:179-94.